Eaton Vance Management’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $14.3M | Sell |
501,952
-242,322
| -33% | -$6.9M | 0.02% | 516 |
|
|
2022
Q2 | $33.7M | Buy |
744,274
+61,411
| +9% | +$2.78M | 0.05% | 348 |
|
|
2022
Q1 | $51.9M | Sell |
682,863
-32,718
| -5% | -$2.49M | 0.06% | 298 |
|
|
2021
Q4 | $107M | Sell |
715,581
-17,666
| -2% | -$2.63M | 0.13% | 154 |
|
|
2021
Q3 | $107M | Buy |
733,247
+8,578
| +1% | +$1.25M | 0.15% | 141 |
|
|
2021
Q2 | $142M | Buy |
724,669
+232,488
| +47% | +$45.5M | 0.19% | 115 |
|
|
2021
Q1 | $89.1M | Buy |
492,181
+221,396
| +82% | +$40.1M | 0.13% | 164 |
|
|
2020
Q4 | $38.3M | Sell |
270,785
-22,830
| -8% | -$3.23M | 0.06% | 294 |
|
|
2020
Q3 | $36.6M | Buy |
293,615
+27,412
| +10% | +$3.42M | 0.07% | 259 |
|
|
2020
Q2 | $23.8M | Buy |
266,203
+16,122
| +6% | +$1.44M | 0.05% | 309 |
|
|
2020
Q1 | $15.6M | Buy |
250,081
+162,308
| +185% | +$10.1M | 0.04% | 333 |
|
|
2019
Q4 | $6.69M | Buy |
87,773
+60,333
| +220% | +$4.6M | 0.01% | 542 |
|
|
2019
Q3 | $1.38M | Buy |
+27,440
| New | +$1.38M | ﹤0.01% | 886 |
|